SynopsisA stent is a small mesh tube that holds open passages in the body, such as weak or narrow arteries. The global Stents & Related Implants market size is expected to reach US$ 18310 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market i.....
SynopsisELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. The global Eloctate market size is expected to reach US$ 996.1 million by 2029, growing at a CAGR of -3.2% from .....
SynopsisDermatophytosis is an infection of the hair, skin, or nails caused by a dermatophyte, which is most commonly of the Trichophyton genus and less commonly of the Microsporum or Epidermophyton genera. Tinea capitis, tinea pedis, and onychomycosis are common derma.....
SynopsisRECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A. The global Recombinant Factor VIII market size is expected to reach US$ 2310.5 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The mar.....
SynopsisEpoetin can be given intravenously or, more conveniently, subcutaneously, when a 25–50% lower dose can be used. The global Epoetin (Eritropoyetin) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market .....
SynopsisLipid Metabolism Disease Drug is usually used to help lipid metabolism. The global Lipid Metabolism Disease market size is expected to reach US$ 12150 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the signif.....
SynopsisA medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for.....
SynopsisAdult Gummy Vitamins are an enjoyable and easy way to get your daily dose of nutrients. The global Adult Gummy Vitamin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the sign.....
SynopsisEculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The global Soliris Drug market size is expected to reach US$ 1746.8 million by 2029, gro.....
SynopsisDrugs used as treatments for asthma and COPD The global Drugs for Asthma and COPD market size is expected to reach US$ 68020 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drug.....
